Key baseline characteristics reported separately for each group | + | − | + | − | − | − | − |
Randomisation procedure clearly described | − | − | + | − | + | − | −− |
Valid measure of FMS | + | + | + | + | + | + | + |
Dropout ≤20% for <6 months follow-up or ≤30% for ≥6 months follow-up | + | − | + | + | + | + | + |
Assessor blinding | − | − | + | + | + | − | − |
Motor development assessed a min of 6 months after pretest | + | − | + | + | − | − | − |
Intention-to-treat analysis | − | − | + | + | + | − | + |
Potential confounders accounted for in analysis | + | + | + | + | + | − | − |
Summary results presented+treatment effect+precision estimates | + | − | + | + | + | − | − |
Power calculation reported | − | − | + | + | − | − | − |
Total score | 6 | 2 | 10 | 8 | 7 | 2 | 3 |